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Summary The Epithelial Membrane Antigen (EMA) has until now only been described in immunological
terms and has been shown immunohistochemically to be present on a variety of human non-squamous
epithelial surfaces. It is a valuable marker in diagnostic tumour pathology and enables the detection of small
deposits of malignant cells in organs such as liver and bone marrow.
Its discovery in soluble form in human milk has enabled a purification of the antigen from this source. The
antigenic activity in the milk is spread over a wide range of mol. wts and although purification causes a
general reduction in size, the antigen remains heterogeneous. Carbohydrate forms the major component of the
antigen with galactose and N-acetylglucosamine as the two major sugars. The protein content of EMA is low
and shows considerable variation in amino acid composition from one sample to another. A high content of
inorganic material has also been found in EMA but is not due to high sulphate or phosphate levels.
Using an antiserum raised against defatted human
cream, Heyderman et al. (1979) have identified a
material which is localised on the luminal and
surface membranes of most non-squamous tissues
in humans. In normal tissues, this material, which
they called epithelial membrane antigen (EMA), is
not found on adjacent cell membranes but only on
that part of the cell surface which is
topographically part of the exterior surface of the
body (Ormerod et al., 1981). Its widespread
distribution suggests that EMA has an important
role and, although this has yet to be defined, we
have hypothesised that it has a protective function
(Sloane et al., 1982).
The production of EMA is increased in both
squamous and non-squamous epithelium in a
variety of diseases including many neoplasms. An
immunohistochemical stain for EMA has
considerable value in certain aspects of cancer
research. It can be used in diagnostic tumour
histopathology and cytology as an indicator of
epithelial differentiation (Sloane & Ormerod, 1981;
To et al., 1981, 1982) and can be used, for example,
to distinguish lymphoma from anaplastic
carcinoma.
A stain for EMA has been used in the routine
histopathology laboratory of the Surrey Branch of
the Royal Marsden Hospital for over 2 years. A
recent review of the results obtained showed that it
was able to assist in a diagnosis of carcinoma in
22/48 problem cases (Sloane et al., 1983).
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In the ectocervix, EMA is absent from normal
squamous cells but is expressed if the epithelium is
disordered in cases of infection, neoplasia and
invasive carcinoma (Sloane et al., 1982; Bamford et
al., 1983). Antisera to EMA can be used to
distinguish abnormal cells in smears made from
cervical scrapes (Moncrieff et al., submitted for
publication).
An immunohistochemical stain for EMA can
identify minute metastatic deposits of carcinoma in
organs such as liver and bone marrow (Sloane et
al., 1980; Dearnaley et al., 1981). Our most recent
studies have shown that EMA positive cells can be
found in the marrows of approximately one third
of patients at the time of surgery for a primary
breast cancer (Dearnaley et al., 1983).
Because of its potential value in the detection and
diagnosis of carcinoma, it is important to learn
more of the chemical nature of this antigen. EMA
is a component of the human milk fat globule
membrane and is found in a soluble form in human
milk. In this paper we describe methods for the
purification of the antigen from this source and
assays for its detection and quantitation, together
with information on the chemical and physical
properties of the antigen.
Materials and methods
Antisera
The anti-EMA sera were raised by the methods
previously published (Ceriani et al., 1977;
Heyderman et al., 1979) by injecting rabbits or
goats with defatted human cream suspended in
complete Freund's adjuvant. The antisera were
absorbed with human plasma, 3M KCI extracts of
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human liver and kidney, non-specific cross-reacting
antigen (von Kleist et al., 1972), lactoferrin and a
fraction from human milk which eluted from a
column of Sepharose 4B in the mol. wt range, 50-
100K daltons. The immunoadsorbents were
prepared by conjugation of the antibody to
Sepharose 6B (Pharmacia Ltd.) by the cyanogen
bromide method.
Goat anti-rabbit and rabbit anti-goat y globulin
sera were raised by priming animals with an
injection of immune complexes formed from
purified IgG and previously raised antisera
suspended in complete Freund's adjuvant. This was
repeated a month later; after a further month the
animals were injected with IgG in incomplete
adjuvant and exsanguinated 2 weeks later. The anti
y-globulin sera were affinity purified on columns of
purified IgG immobilised on Sepharose 6B. The
specific antibodies were eluted with 0.2M glycine-
HCI buffer, pH 2.3.
The affinity-column for preparing anti-EMA
antibodies was made by linking purified EMA to
the amino groups of 1,6-diaminohexane-Sepharose
(AH-Sepharose 4B; Pharmacia Ltd.) using 1-ethyl-
3-(3-dimethylamino-propyl) carbodiimide (Sigma
Ltd.) and- following the instruction supplied by
Pharmacia. The antibodies were eluted from the
column using glycine-HCl, pH 2.3.
Column chromatography
The Sepharose 6B (Pharmacia Ltd.) columns
(44x600mm) were run at 30mlh-1 and 0ml
fractions were collected. The elution buffer was
0.1 M phosphate, 0.25 MNaCl, 1 mM EDTA,
3mMNaN3, 0.1% Triton X-l00, pH8.0. They were
calibrated using blue dextran, spleen ferritin
(mol. wt=440 K daltons), IgG (150 K daltons),
bovine serum albumin (67 Kdaltons) and
cytochrome C (12.5 K daltons).
The cation exchange column (260 x 15mm)
contained carboxymethyl-Sephadex C-25
(Pharmacia Ltd.), equilibrated with 0.1M acetate,
0.01 M NaCl, pH 6.
Chemical analysis
Monosaccharide analysis was performed according
to the method of Clamp et al. (1971) using a
Perkin-Elmer F-30 gas chromatograph as described
by Westwood & Thomas (1975). The amino acid
analysis was made using a Biotronik LC2000
analyser. Determination of ash content after
combustion was by Butterworth Laboratories Ltd.
Protein concentrations were determined using a
Bio-Rad kit which measures the binding of
Coomassie Brilliant Blue with ovalbumin as a
standard, and using the Lowry method.
Polyacrylamide gel electrophoresis
Polyacrylamide (62%) running gels in 0.375M tris-
HCI buffer, pH 8.9 were cast in 5mm glass tubes to
a length of 55mm and overlaid with 3% gels
(10mm long) in tris-HCI buffer, pH 6.7. The
electrode buffer was 0.025M tris, 0.192M glycine,
pH8.6, and the upper buffer only contained 0.03%
sodium dodecyl sulphate (SDS). The sample was
made 1% in SDS. After electrophoresis, the gels
were cut into 1 mm slices, each slice placed in a well
of a micro-titer plate (A/S Nunc, Denmark) and
100 pI of antiserum at a dilution of 1 in 1000
added. After 16h at room temperature, 50 ul from
each well was added to a Removawell (Dynatech)
coated with EMA and the procedure for
radioimmunoassay described below was followed.
Smith degradation ofEMA
A solution of EMA (EMA Dl) in 0.2M sodium
acetate buffer (pH4) containing 5mM sodium
periodate was kept at 20°C for 16h in the dark.
Excess of periodate was consumed using 1,2-
propane-diol and after dialysis with water the
product was reduced with sodium borohydride in
carbonate/bicarbonate buffer (pH9.2,0.2M) for 5h
at 20°C. The acid hydrolysis stage was carried out
using 0.05M sulphuric acid at 370C for 22h. The
product was dialysed with water, further purified
on a P-2 (Bio-Rad) column and analysed for
monosaccharides. Its antigenic activity was
determined in the EMA radioimmunoassay.
Results
Assayfor Epithelial Membrane Antigen
Establishing a method for the purification of EMA
depended on a means of detecting the antigen.
Immunodiffusion, immunoelectrophoresis and
crossed immunoelectrophoresis of either milk or
extracts of the milk fat globule membrane showed
that the antigen did not form sharp precipitation
lines on reaction with the antibody. Since EMA
was discovered from the reaction of an antiserum
with sections cut from formalin-fixed paraffin-
embedded tissue by an immunohistochemical
method (Heyderman et al., 1979), we used this to
detect EMA at the start of the purification.
When a crude preparation of EMA had been
made, a radioimmunoassay was established. This
was used to improve the purification procedure and
to prepare EMA which was used in the
radioimmunoassay described below.
Skimmed human milk was fractionated with
(NH4)2 S04 and material of mol.wt > 106 was
collected from a column of Sepharose 6B as
described below. After extraction with chloroform-EPITHELIAL MEMBRANE ANTIGEN 535
methanol (6 parts chloroform: 3 parts methanol: 1
part aqueous solution), the EMA activity was
recovered in the aqueous phase. This material was
dialysed and used in the assay.
The solution of EMA was diluted in carbonate
buffer, pH 9.6, and 50u1 added to small polystyrene
wells (Removawell, Dynatech Ltd). Thereafter all
dilutions and washings used phosphate buffered
saline (0.1 M phosphate, 0.15MNaCl, 3mM NaN3,
pH7.5), containing 1% bovine serum albumin.
Twenty-five p1 of goat anti-EMA serum at a
dilution of 1 in 100 was added in separate wells to
100 p1 of each test fraction diluted as appropriate.
After incubation at ambient temperature overnight,
the Removawells were washed thoroughly and 50MI
of the antiserum-test sample mix was added. After
2h at ambient temperature, the wells were washed,
incubated with 125I-labelled anti-goat y-globulins
(0.2pCi per well) for 1h, washed and counted. A
particular sample of milk was set aside for use as a
standard for this assay. In later work a purified
sample of EMA has been used as a standard.
Typical curves obtained by this procedure are
shown in Figure 1. The data given in the rest of
this paper were obtained using this assay.
Any impurity in the EMA preparation to which
there was an an antibody in the antiserum would
interfere in the assay. To check this, the purer
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Figure 1 Radioimmunoassay for EMA as described
in the text. Bo/B -1 is plotted against either
concentration of pure EMA or dilution of milk on a
double log scale where Bo are the counts bound in the
absence of EMA and B the counts bound in the
presence of the unlabelled antigen.
preparations of EMA were used to afflnity-purify
goat antibodies (see Materials and methods) and a
radioimmunometric assay was established. Gamma
globulins from a rabbit antiserum were absorbed to
the Removawells by incubation at pH9.6. After
washing, dilutions of either purified EMA or of the
test sample were added to the wells and left
overnight. After further washing, the wells were
incubated with affinity-purified goat antibodies,
washed and finally incubated with 125I-rabbit anti-
goat antibodies. Using this alternative assay, the
purification procedure was re-checked. No
significant difference was found in the results using
the two assays.
Purification procedures
Table I shows the results obtained during a typical
preparation of EMA.
Human milk (11), pooled from different donors
and after removal of the cream, was brought to
40% saturation with (NH4)2SO4 and the precipitate
removed by centrifugation. The supernatant (which
contained 75% of the EMA activity) was brought
to 80% saturation with (NH4)2SO4, the precipitate
collected, dissolved and dialysed against distilled
water, concentrated and made 1% in the detergent
Triton X-100. This material was divided into four
and each part fractionated on a column of
Sepharose 6B, 0.1% Triton X-100, pH 8.0. The
active fractions which eluted in a position
corresponding to a mol. wt > 106 (Figure 2) were
bulked, concentrated and then stirred with 6vol of
chloroform and 3 of methanol. After separation,
the organic phase and the precipitated proteins at
the interface were discarded . The aqueous phase
Table I Stage by stage comparison of amounts of
protein' and EMA2 during purification of EMA from 11
milk
Stage ofpurification Protein (mg) EMA (mg)3
Skimmed milk 11,280 597
40-80% (NH4)2SO4
precipitate 7,904 340
Sepharose 6B 710 319
Chloroform-
methanol extraction 43 266
CM Sephadex 40.8 254
Peanut lectin affinity
column 12.3 194
'Determined using the Bio-Rad assay.
2Determined using the radioimmunoassay described in
this paper.
3This value is calculated assuming that the final
purification stage gives pure EMA.
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Figure 2 Chromatography on Sepharose 6B. Material in skimmed milk which was soluble at 40% saturation
(NH4)2SO4 was made 1% in Triton X-100 and eluted in phosphate buffer, 0.1% Triton X-100, pH 8.0. The
arrows show the positions at which different markers start to elute. 1-Dextran Blue (void volume); 2-ferritin
(mol. wt=440K daltons); 3-bovine serum albumin (mol. wt=67K daltons); 4-cytochrome C (mol. wt= 12.5K
daltons). (- ) EMA activity as measured in a radioimmunoassay; (----) Optical density at 280 nm; (-----)
Protein concentration.
was dialysed against water, concentrated, made
0.01 M in acetate, pH6.0, and applied to a column
of the ion exchange resin carboxymethyl Sephadex
C-25 equilibrated in the same buffer. The major
active fraction was washed off in 160ml of the
starting buffer. The remaining activity and proteins
were eluted with 0.25 M NaCl, 0.01 M acetate,
pH6.0 (Figure 3). After extensive dialysis against
water, some of this material was freeze dried in
order to estimate the dry weight. The remainder
was applied to a column of peanut lectin
immobilised on Sepharose 4B. Ninety-one percent
of the applied activity bound to the lectin and 93%
of the bound activity was eluted with 2% galactose.
This material was dialysed against water and freeze
dried.
Some of the batches of EMA were purified by
omitting the ion exchange column and substituting
an affinity column of wheat germ lectin bound to
Sepharose 4B. EMA activity bound to the column
and was eluted with 10% N-acetyl D-glucosamine.
After dialysis against distilled water the active
material was applied to a column of peanut lectin.
Chemical andphysicalproperties
Table II shows the values of the gross composition
of four different samples of EMA. The total
amount of carbohydrate in the antigen was variable
but always constituted the major detected
component. Protein composition also varied from
one preparation of antigen to another and was
typically low. Variation was also found in the value
obtained for the protein content of particular EMA
preparations depending on the method used for
determination. The samples had a high content of
inorganic material as demonstrated by the weight of
ash found. We have been unable to remove this
inorganic material despite extensive dialysis. The
phosphate and sulphate contents of one sample of
EMA were determined and both were <1% of
total wt. Heating a sample of EMA at 110°C to
remove water reduced the wt by only 5%.
The monosaccharide compositions of the 4
preparations of EMA are shown in Table III.
Galactose is the major monosaccharide in EMA
showing a consistent value of -40%. This was not
an artefact caused by insufficient dialysis after
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Figure 3 Cation exchange chromatography on
carboxymethyl-Sephadex. The active material from the
column shown in Figure 2 was applied in 0.01 M
acetate, 0.01 MNaCl, pH6.0 and eluted with this
buffer. At the point marked with an arrow the
concentration of NaCl was increased to 0.25M.
affinity purification on peanut lectin since material
obtained from the ion exchange column before
further purification on the peanut lectin also
contained large quantities of galactose as did a
sample which was affinity purified on immobilised
goat anti-EMA antibodies. N-acetyl-glucosamine is
also a major sugar in all of the preparations. Other
sugars are present in the antigen in more variable
quantities.
When one of the samples of EMA (EMADl)
was treated in sequence with periodate, borohydride
and dilute acid (i.e. degraded according to the
procedure of Smith (Hay et al., 1965)) a
considerable simplification of monosaccharide
composition of the antigen was achieved (Table III)
with no apparent loss in antigenic activity of the
antigen (Figure 4). N-acetyl-glucosamine, galactose
and N-acetyl-galactosamine were the only
significant remaining sugars and were present in the
simple molecular ratio of 2: 1: 1.
Amino acid analyses of the protein portion
showed considerable variation. A consistent feature
was the absence of tyrosine which accords with the
difficulty encountered in attempting to label the
antigen with 125I.
The process of purification reduced the mol. wt
of EMA, although it still had a very heterogeneous
spread of mol. wts between 106 . and 5.104
Table II Composition (by wt) ofpurified EMA preparations
EMA preparation EMA M4 EMA DI EMA S18 EMA S21
Carbohydrate (%) 58.0 22.9 24.5 40.0
Protein (%) 14.01; 16.02 13.61; 6.62 6.62 4.72
Ash (%) 9.7 ND 18.6 16.8
'Determined using the Lowry protein assay.
2Determined from the amino-acid analysis of the sample.
ND =not determined.
Table m Monosaccharide analysis (mole %) of EMA and Smith-degraded EMA Dl
Smith degraded
EMA preparation EMA M4 EMA DI EMA S18 EMA S21 EMA Dl
Fucose 3.7 4.7 4.5 7.1 1.0
Mannose 0.9 3.8 15.2 5.9 1.8
Glucose 2.7 13.6 12.8 6.2 2.6
Galactose 42.9 42.8 38.1 42.6 24.5
GlcNAc 32.3 19.9 18.6 26.8 48.9
GalNAc 16.8 12.7 11.0 11.5 21.1
Sialic acid' 1.7 2.5 ND ND none
'Determination using the colorimetric method ofWarren (1959).
ND =not determined.538 M.G. ORMEROD et al.
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Figure 4 Radioimmunoassay of EMA (x) and
Smith-degraded EMA (0). Bo/B-1 is plotted against
the concentration of either EMA or modified EMA on
a double log scale where Bo are the counts bound in
the absence of antigen and B the counts bound in the
presence of antigen.
(Figure 5). The activity of EMA was unaffected by
placing a solution in a boiling water bath for 2min.
It was also unaffected by heating to 90°C for 2min
in the presence of 3% SDS and 1%
mercaptoethanol. On a polyacrylamide gel at
pH 8.6 the EMA activity had a low electrophoretic
mobility in the presence or absence of SDS.
Figure 6 shows a comparison of EMA activities in
skimmed milk and a preparation of EMA. The
latter had a wide range of mobilities consistent with
a larger spread of mol. wt.
Treatment with trypsin (1 mg per 10mg protein)
for 17h at 37OC had no effect on the EMA activity.
Treatment wiLn pronase (1 mg per 10mg protein)
for 2h at 37°C also had no effect but if the
incubation was extended to 17h, there was a
lowering of activity. This is an excessive length of
treatment for this enzyme and the effect could have
been due to trace impurities in the pronase sample
and not its proteolytic activity. EMA could be
exposed for up to 4h to either 1 M acetic acid or
6M guanidine without effect but exposure for 18h
or more did lead to loss of activity. If exposure to
either acetic acid or guanidine is not excessive, then
columns in either of these reagents can give a
considerable purification of EMA at an early stage
in the procedure. However, these columns removed
little that was not removed by extraction with
chloroform/methanol.
As well as binding to peanut lectin, EMA also
bound to wheat germ lectin. Despite its mannose
50[
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60
Figure 5 Purified EMA on a column of Sepharose-
CL 4B. Eluted in phosphate buffer, 0.1% Triton X-
100. The arrows show the positions at which different
markers start to elute. From left to right, blue dextran
(void volume); IgM (mol. wt=800K daltons); IgG
(mol. wt = 150K daltons); bovine serum albumin
(mol.wt=67K daltons).
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300
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Figure 6 6j% polyacrylamide gels run in SDS. The
direction of migration is from left to right. The small
peak of activity at the end of the gel marks the solvent
front and is due to the higher concentration of SDS at
this position interfering in the radioimmunoassay. (a)
Skimmed milk; (b) Purified EMA.
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content, EMA did not react with Concanavalin A
although the active material which precipitated with
40% (NH4)2SO4 did bind to ConA; this ConA
reactivity could be removed by treatment with
trypsin.
Discussion
Antibodies to EMA have now been proved to be of
value in diagnostic tumour histopathology and have
demonstrated the presence of the antigen on
different epithelial tissues. However, the nature of
the molecules which carry the antigenic
determinants and the structures of the determinants
are not known. It would be of interest to know if
the molecules which carry the determinants are the
same in each tissue and also whether there are any
variations in the determinants carried by different
tissues and whether their pattern changes in
neoplasia.
The discovery of EMA in a soluble form in
human milk presented an opportunity to purify the
antigen and thereby to examine the structure of the
molecules. As our attempts at purification
proceeded, it became clear that the antigenic
determinants were not carried on one well-defined
molecule but that we were dealing with a
heterogeneous set. This is evident from the spread
of apparent mol. wt on the Sepharose column.
EMA is present in the membrane of the milk fat
globules which have arisen from the apical
membranes of the secretory cells of the breast and
the soluble antigen is probably formed by
degradation of milk fat globule membranes in
the milk. This degradative process might explain
the variability in the protein content. The vari-
ation from one preparation to another was far
higher than would be expected even taking into
consideration the low protein content of the final
product. Batches of milk from different women
might vary appreciably in the extent to which the
antigen had been degraded. An alternative
explanation for the variability in protein is that
much of this material is impure. This seems unlikely
since on SDS-polyacrylamide gels the only protein
band observed (and that was very weak) co-eluted
with the EMA activity as measured by the
radioimmunoassay. We have found previously that
such gels would separate EMA from casein with
which the antigen had been co-purified (Ormerod et
al., 1982).
During the process of isolation there was further
breakdown of the antigen as is shown by a
comparison of Figures 2 and 5. There was little
evidence that this was due to proteolysis and it may
have been caused by breaking strong hydrophobic
links.
The most effective purification steps were the
chloroform-methanol extraction and the peanut
lectin affinity column. The precipitation with 40%
(NH4)2SO4 did not increase the EMA/protein ratio
in itself but removed a lot of material of high
mol. wt which would have interfered with the
purification on the Sepharose 6B column. The ion-
exchange column did not improve the ratio of
EMA to protein but it did remove some non-
proteinaceous material and was therefore retained
in the purification procedure.
Two other perplexing features of the purification
were our inability to account for all of the material
present and the high ash content. With different
samples we could account for between 45 and 80%
of the total wt in terms of carbohydrate, protein
and inorganic material. It is unlikely that much
lipid is present as a lipid would be expected to
partition into the organic phase during the
chloroform-methanol extraction. The ash present
was not phosphate or sulphate. Whatever its
composition, it was firmly bound to the sample
since the EMA had been affinity purified on peanut
lectin after it had last been dissolved in a buffer.
Thereafter it was handled in distilled water.
While the protein content of the preparations of
EMA was low, carbohydrate constituted the major
identified part of the preparations with galactose
and N-acetyl-glucosamine being the predominant
sugars; five other sugars, however, were also
identified. Smith degradation considerably
simplified the carbohydrate composition leaving N-
acetyl-glucosamine, galactose and N-acetyl-
galactosamine, in the molecular ratio of 2: 1: 1,
respectively; the modified antigen retained its
antigenic activity. This may mean that the major
antigenic determinants contain a combination of
these sugars particularly as removal of the majority
of the sugars from the antigen using neuraminidase
and a mixture of glycosidases isolated from
Trichomonas foetus (Watkins, 1966) caused a large
reduction in antigenic activity (unpublished results)
whereas treatment of EMA with trypsin caused
little loss in EMA activity. Although the Smith
degradation of EMA would be expected to destroy
carbohydrate determinants, it may also expose
cryptic carbohydrate structures similar to the ones
which originally bound to the antiserum.
Recently, Shimizu & Yamuchi (1982) have
extracted a mucin-like glycoprotein from the human
milk fat globule membrane using a mixture of
deoxycholate, urea and mercaptoethanol. This
glycoprotein has many properties similar to EMA
but it will only be possible to confirm the identity
of the two materials by comparing them in a
radioimmunoassay.
It is clear from our results that our polyclonal
antisera, while identifying a ubiquitous structure540 M.G. ORMEROD et al.
associated with epithelial differentiation and of
practical importance in cancer research, are not
reacting with a simple molecular species. We have
probably isolated a set of products resulting from
the breakdown of a much larger component of the
membrane. We present the purification method
developed now because it produces a product which
can be used to absorb antisera (an important
control in immunohistochemical work), it forms the
basis of our radioimmunoassay which can be used
to detect EMA released in the plasma of patients
with breast cancer (Ormerod et al., in preparation),
and it gives the starting material for more detailed
work on the structure of the antigenic
determinants. This will be achieved by a variety of
methods including selective degradation of the
carbohydrate structure. There are now, in addition
to the polyclonal antisera used for the work
described in this paper, 5 monoclonal antibodies
available, one raised in the Ludwig Institute for
References
BAMFORD, P.N., ORMEROD, M.G., SLOANE, J.P. &
WARBURTON, M.J. (1983). An immunohistochemical
study of the distribution of epithelial antigens in the
uterine cervix. Obstet. Gynecol., 41, 603.
CERIANI, R.L., THOMPSON, K., PETERSON, J.A. &
ABRAHAM, S. (1977). Surface differentiation antigens
of human mammary epithelial cells carried on the
human milk fat globule. Proc. Natl Acad. Sci., 74, 582.
CLAMP, J.R., BHATTI, T. & CHAMBERS, R.E. (1971) The
determination of carbohydrate in biological materials
by gas liquid chromatography. Meth. Biochem. Anal.,
19, 229.
DEARNALEY, D.P., ORMEROD, M.G., SLOANE, J.P. & 5
others (1983). Detection of isolated mammary
carcinoma cells in the marrow of patients with primary
breast cancer, Proc. R. Soc. Med., 76, 359.
DEARNALEY, D.P., SLOANE, J.P., ORMEROD, M.G.,
STEELE, K & 6 others (1981). Increased detection of
mammary carcinoma cells in marrow smears using
antisera to epithelial membrane antigen. Br. J. Cancer,
44, 85.
FOSTER, C.S., EDWARDS, P.A.W., DINSDALE, E.A. &
NEVILLE, A.M. (1982). Monoclonal antibodies to the
human mammary gland. I. Virchows Arch. (Pathol.
Anat.) 394, 279.
HAY, G.W., LEWIS, B.A. & SMITH, F. (1965). Periodate
oxidation of polysaccharides: General procedures. In:
Methods in Carbohydrate Chemistry, Vol. 5, (Ed.
Whistler) p. 357. Academic Press: New York.
HEYDERMAN, E., STEELE, K. & ORMEROD, M.G. (1979).
A new antigen on the epithelial membrane: its
immunoperoxidase localisation in normal and
neoplastic tissues. J. Clin. Pathol., 32, 35.
LOWRY, O.H., ROSENBROUGH, N.J., FARR, A.L. &
RANDALL, R.J. (1951). Protein measurement with the
Folin phenol reagent. J. Biol. Chem., 193, 265.
ORMEROD, M.G., BUSSULATI, G., SLOAN, J.P., STEELE,
K. & GUGLIOTTA, P. (1982). Virchows. Arch., 397, 327.
Cancer Research (Foster et al., 1982), 2 in the
Imperial Cancer Research Fund (Taylor-
Papadimitriou et al., 1981) and 2 in the Institute of
Cancer Research (Summerhayes & Pocock, work in
progress). These antibodies are currently being used
to explore the different epitopes of the antigen.
We thank Prof. A.M. Neville for his helpful
encouragement and advice during the work and Dr. Anne
Neville for organising the supply of, and the nursing
mothers for supplying, the human milk. We also thank
the following people: Dr. E. Heyderman for her
immunohistochemical testing for EMA in the early stages
of the work, Mr. C.L. Day and Dr. A.M. Bukhari for
their skilled technical assistance, and Dr. M. Warburton
for the amino acid analyses. The work was supported by
grants from the Medical Research Council. One of us
(M.N.M.) thanks the Consejo Nacional de Investigaciones
Cientificas y Technicas de la Republica Argentina for her
support.
ORMEROD, M.G., MONAGHAN, P., EASTY, D. & EASTY,
G.C. (1981). Asymmetrical distribution of epithelial
membrane antigen on the plasma membrane of human
breast cell lines in culture. Diagn. Histopathol., 4, 89.
SHIMIZU, M. & YAMAUCHI, K. (1982). Isolation and
characterisation of mucin-like glycoprotein in human
milk fat globule membrane. J. Biochem., 91, 515.
SLOANE, J.P., HUGHES, F. & ORMEROD, M.G. (1983). An
assessment of the value of epithelial membrane antigen
and other epithelial markers in solving diagnostic
problems in tumour histopathology. Histochem. J., 15,
645.
SLOANE, J.P., ORMEROD, M.G., CARTER, R.L.,
GUSTERSON, B.A. & FOSTER, C.S. (1982). An
immunocytochemical study of the distribution of
epithelial membrane antigen in normal and disordered
squamous epithelium. Diagn. Histopathol., 5, 11.
SLOANE, J.P. & ORMEROD, M.G. (1981). Distribution of
epithelial membrane antigen in normal and neoplastic
tissues and its value in diagnostic tumor pathology.
Cancer, 47, 1786.
SLOANE, J.P., ORMEROD, M.G., IMRIE, S.F. & COOMBES,
R.C. (1980). The use of antisera to epithelial membrane
antigen in detecting micrometastases in histological
sections. Br. J. Cancer, 42, 392.
TAYLOR-PAPADIMITRIOU, J., PETERSON, J.A., ARKLIE,
J., BURCHELL, J., CERIANI, R.L. & BODMER, W.F.
(1981). Monoclonal antibodies to epithelium-specific
components of the human milk fat globule membrane:
production and reaction with cells in culture. Int. J.
Cancer, 28, 17.
TO, A., COLEMAN, D.V., DEARNALEY, D.P., ORMEROD,
M.G., STEELE, K., & NEVILLE, A.M. (1981). Use of
antisera to epithelial membrane antigen for the
cytodiagnosis of malignancy in serous effusions. J.
Clin. Pathol., 34, 1326.EPITHELIAL MEMBRANE ANTIGEN 541
TO, A., DEARNALEY, D.P., ORMEROD, M.G., CANTI, G. &
COLEMAN, D.V. (1982). Epithelial Membrane Antigen:
Its use in the diagnosis of malignancy in serous
effusions. Am. J. Clin. Pathol., 78, 214.
VON KLEIST, S., CHAVANEL, G. & BURTIN, P. (1972).
Identification of an antigen from normal human tissue
that cross-reacts with carcinoembryonic antigen. Proc.
Natl Acad. Sci., 69, 2492.
WATKINS, W.M. (1966). Enzymes that destroy blood-
group specificity. Methods Enzymol., 8, 700.
WESTWOOD, J.H. & THOMAS, P. (1975). Studies on the
structure and immunological activity of
carcinoembryonic antigen-the role of disulphide
bonds. Br. J. Cancer, 32, 708.